{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:11:01Z","timestamp":1764843061127,"version":"3.46.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12029-025-01364-z","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:06:29Z","timestamp":1764842789000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sociodemographic Determinants Associated with the Receipt of Adjuvant Chemotherapy in Stage III Colorectal Cancer: A Population-Based Study from the SEER Registry"],"prefix":"10.1007","volume":"56","author":[{"given":"Sameh Hany","family":"Emile","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Horesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe","family":"Garoufalia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjelli","family":"Wignakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marylise","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven D.","family":"Wexner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"1364_CR1","unstructured":"Key Statistics for Colorectal Cancer. American Cancer Society. 2025. Available online at https:\/\/www.cancer.org\/cancer\/types\/colon-rectal-cancer\/about\/key-statistics.html#:~:text=About%20106%2C590%20new%20cases%20of,older%20adults%20for%20several%20decades. Accessed on 25 Feb 2025."},{"key":"1364_CR2","doi-asserted-by":"publisher","first-page":"5356","DOI":"10.3390\/curroncol28060447","volume":"28","author":"K Chen","year":"2021","unstructured":"Chen K, Collins G, Wang H, Toh JWT. Pathological features and prognostication in colorectal cancer. Curr Oncol. 2021;28:5356\u201383. https:\/\/doi.org\/10.3390\/curroncol28060447.","journal-title":"Curr Oncol"},{"key":"1364_CR3","doi-asserted-by":"publisher","first-page":"e240029","DOI":"10.6004\/jnccn.2024.0029","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson AB, Venook AP, Adam M, et al. Colon Cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024;22:e240029. https:\/\/doi.org\/10.6004\/jnccn.2024.0029.","journal-title":"J Natl Compr Canc Netw"},{"key":"1364_CR4","doi-asserted-by":"publisher","first-page":"366","DOI":"10.6004\/jnccn.2024.0041","volume":"22","author":"AB Benson","year":"2024","unstructured":"Benson AB, Venook AP, Adam M, et al. NCCN Guidelines\u00ae insights: rectal Cancer, version 3.2024. J Natl Compr Canc Netw. 2024;22:366\u201375. https:\/\/doi.org\/10.6004\/jnccn.2024.0041.","journal-title":"J Natl Compr Canc Netw"},{"key":"1364_CR5","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1200\/JCO.22.00046","volume":"41","author":"D Morton","year":"2023","unstructured":"Morton D, Seymour M, Magill L, et al. FOxTROT collaborative Group. Preoperative chemotherapy for operable colon cancer: mature results of an international randomized controlled trial. J Clin Oncol. 2023;41:1541\u201352. https:\/\/doi.org\/10.1200\/JCO.22.00046.","journal-title":"J Clin Oncol"},{"key":"1364_CR6","unstructured":"Sanoff H. Adjuvant therapy for resected stage II colon cancer. UpToDate. 2025. Available online at https:\/\/www.uptodate.com\/contents\/adjuvant-therapy-for-resected-stage-ii-colon-cancer#:~:text=Largely%20based%20upon%20these%20data,benefit%20from%20adjuvant%20chemotherapy%2C%20and. Accessed on 25 Feb 2025."},{"key":"1364_CR7","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.3390\/cancers12092679","volume":"12","author":"J Taieb","year":"2020","unstructured":"Taieb J, Gallois C. Adjuvant chemotherapy for stage III colon cancer. Cancers (Basel). 2020;12:2679. https:\/\/doi.org\/10.3390\/cancers12092679.","journal-title":"Cancers (Basel)"},{"key":"1364_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.ejca.2010.01.020","volume":"46","author":"G Des Guetz","year":"2010","unstructured":"Des Guetz G, Nicolas P, Perret G-Y, Morere J-F, Uzzan B. Does delaying adjuvant chemotherapy after curative surgery for colorectal cancer impair survival? A meta-analysis. Eur J Cancer. 2010;46:1049\u201355. https:\/\/doi.org\/10.1016\/j.ejca.2010.01.020.","journal-title":"Eur J Cancer"},{"key":"1364_CR9","doi-asserted-by":"publisher","first-page":"e000087","DOI":"10.1136\/esmoopen-2016-000087","volume":"1","author":"CM Lund","year":"2016","unstructured":"Lund CM, Nielsen D, Dehlendorff C, et al. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colorectal cancer: the ACCORE study. ESMO Open. 2016;1:e000087. https:\/\/doi.org\/10.1136\/esmoopen-2016-000087.","journal-title":"ESMO Open"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/archsurg.135.2.182","volume":"135","author":"T Mahoney","year":"2000","unstructured":"Mahoney T, Kuo YH, Topilow A, Davis JM. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg. 2000;135:182\u20135. https:\/\/doi.org\/10.1001\/archsurg.135.2.182.","journal-title":"Arch Surg"},{"key":"1364_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/cncr.27755","volume":"119","author":"A Abraham","year":"2013","unstructured":"Abraham A, Habermann EB, Rothenberger DA, et al. Adjuvant chemotherapy for stage III colon cancer in the oldest old: results beyond clinical guidelines. Cancer. 2013;119:395\u2013403. https:\/\/doi.org\/10.1002\/cncr.27755.","journal-title":"Cancer"},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/cam4.632","volume":"5","author":"MC Hsieh","year":"2016","unstructured":"Hsieh MC, Thompson T, Wu XC, et al. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients. Cancer Med. 2016;5:871\u201380. https:\/\/doi.org\/10.1002\/cam4.632.","journal-title":"Cancer Med"},{"key":"1364_CR13","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/SLA.0000000000000312","volume":"258","author":"RP Merkow","year":"2013","unstructured":"Merkow RP, Bentrem DJ, Mulcahy MF, et al. Effect of postoperative complications on adjuvant chemotherapy use for stage III colon cancer. Ann Surg. 2013;258:847\u201353. https:\/\/doi.org\/10.1097\/SLA.0000000000000312.","journal-title":"Ann Surg"},{"key":"1364_CR14","doi-asserted-by":"publisher","first-page":"116191","DOI":"10.1016\/j.amjsurg.2025.116191","volume":"242","author":"SH Emile","year":"2025","unstructured":"Emile SH, Horesh N, Garoufalia Z, et al. Household income is independently associated with overall and cancer-specific survival after proctectomy for rectal cancer: A surveillance, epidemiology, and end results-based analysis. Am J Surg. 2025;242:116191. https:\/\/doi.org\/10.1016\/j.amjsurg.2025.116191.","journal-title":"Am J Surg"},{"key":"1364_CR15","unstructured":"Percentage distribution of household income in the United States. from 2006 to 2022. Statista. Available online in https:\/\/www.statista.com\/statistics\/758502\/percentage-distribution-of-household-income-in-the-us\/. Accessed on 26 Feb 2026."},{"key":"1364_CR16","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1056\/NEJMoa010957","volume":"345","author":"DJ Sargent","year":"2001","unstructured":"Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med. 2001;345:1091\u20137.","journal-title":"N Engl J Med"},{"key":"1364_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejca.2021.01.051","volume":"148","author":"G Rosati","year":"2021","unstructured":"Rosati G, Lonardi S, Galli F, et al. TOSCA (Three or six colon Adjuvant) investigators. Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial. Eur J Cancer. 2021;148:190\u2013201. Epub 2021 Mar 18. PMID: 33744715.","journal-title":"Eur J Cancer"},{"key":"1364_CR18","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12875-016-0440-0","volume":"17","author":"AE Thompson","year":"2016","unstructured":"Thompson AE, Anisimowicz Y, Miedema B, et al. The influence of gender and other patient characteristics on health care-seeking behaviour: a QUALICOPC study. BMC Fam Pract. 2016;17:38. https:\/\/doi.org\/10.1186\/s12875-016-0440-0.","journal-title":"BMC Fam Pract"},{"key":"1364_CR19","doi-asserted-by":"publisher","first-page":"568417","DOI":"10.3389\/fonc.2020.568417","volume":"10","author":"SKR Mukkamalla","year":"2020","unstructured":"Mukkamalla SKR, Huynh DV, Somasundar PS, Rathore R. Adjuvant chemotherapy and tumor sidedness in stage II colon cancer: analysis of the National cancer data base. Front Oncol. 2020;10:568417. https:\/\/doi.org\/10.3389\/fonc.2020.568417.","journal-title":"Front Oncol"},{"key":"1364_CR20","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1200\/JCO.23.00539","volume":"42","author":"LM Nogueira","year":"2024","unstructured":"Nogueira LM, May FP, Yabroff KR, Siegel RL. Racial disparities in receipt of Guideline-Concordant care for Early-Onset colorectal cancer in the united States. J Clin Oncol. 2024;42:1368\u201377. https:\/\/doi.org\/10.1200\/JCO.23.00539.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1364_CR21","doi-asserted-by":"publisher","first-page":"e107","DOI":"10.1016\/j.amepre.2016.02.025","volume":"51","author":"AN Burnett-Hartman","year":"2016","unstructured":"Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA, PROSPR Consortium. Racial\/Ethnic disparities in colorectal cancer screening across healthcare systems. Am J Prev Med. 2016;51(4):e107\u201315. https:\/\/doi.org\/10.1016\/j.amepre.2016.02.025.","journal-title":"Am J Prev Med"},{"key":"1364_CR22","doi-asserted-by":"publisher","first-page":"100619","DOI":"10.1016\/j.ctarc.2022.100619","volume":"32","author":"XL Du","year":"2022","unstructured":"Du XL, Song L. Racial disparities in treatments and mortality among a large population-based cohort of older men and women with colorectal cancer. Cancer Treat Res Commun. 2022;32:100619. https:\/\/doi.org\/10.1016\/j.ctarc.2022.100619.","journal-title":"Cancer Treat Res Commun"},{"key":"1364_CR23","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/jnci\/djaa182","volume":"113","author":"RA Snyder","year":"2021","unstructured":"Snyder RA, Hu CY, Zafar SN, Francescatti A, Chang GJ. Racial disparities in recurrence and overall survival in patients with locoregional colorectal cancer. J Natl Cancer Inst. 2021;113:770\u20137. https:\/\/doi.org\/10.1093\/jnci\/djaa182.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1364_CR24","doi-asserted-by":"publisher","first-page":"e2350844","DOI":"10.1001\/jamanetworkopen.2023.50844","volume":"7","author":"S Kircher","year":"2024","unstructured":"Kircher S, Duan F, An N, et al. Patient-Reported financial burden of treatment for colon or rectal cancer. JAMA Netw Open. 2024;7(1):e2350844. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.50844.","journal-title":"JAMA Netw Open"},{"key":"1364_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/COC.0b013e3181d2ed93","volume":"34","author":"KL Foley","year":"2011","unstructured":"Foley KL, Tooze JA, Klepin HD, Song EY, Geiger AM. Adjuvant chemotherapy among medicaid-enrolled patients diagnosed with nonmetastatic colon cancer. Am J Clin Oncol. 2011;34:120\u20134. https:\/\/doi.org\/10.1097\/COC.0b013e3181d2ed93.","journal-title":"Am J Clin Oncol"},{"key":"1364_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cllc.2024.09.007","volume":"26","author":"H Rshaidat","year":"2025","unstructured":"Rshaidat H, Mack SJ, Koeneman SH, et al. The role of medicaid expansion on the receipt of adjuvant chemotherapy in patients with lung cancer. Clin Lung Cancer. 2025;26:131\u20139. https:\/\/doi.org\/10.1016\/j.cllc.2024.09.007.","journal-title":"Clin Lung Cancer"},{"key":"1364_CR27","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1245\/s10434-014-3631-8","volume":"21","author":"JM Weiss","year":"2014","unstructured":"Weiss JM, Schumacher J, Allen GO, et al. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data. Ann Surg Oncol. 2014;21:1781\u201391. https:\/\/doi.org\/10.1245\/s10434-014-3631-8.","journal-title":"Ann Surg Oncol"},{"key":"1364_CR28","doi-asserted-by":"publisher","first-page":"zrae038","DOI":"10.1093\/bjsopen\/zrae038","volume":"8","author":"HG Smith","year":"2024","unstructured":"Smith HG, Nilsson PJ, Shogan BD, et al. Neoadjuvant treatment of colorectal cancer: comprehensive review. BJS Open. 2024;8:zrae038. https:\/\/doi.org\/10.1093\/bjsopen\/zrae038.","journal-title":"BJS Open"},{"key":"1364_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.annepidem.2003.08.002","volume":"14","author":"K Demissie","year":"2004","unstructured":"Demissie K, Oluwole OO, Balasubramanian BA, Osinubi OO, August D, Rhoads GG. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between Whites and Blacks. Ann Epidemiol. 2004;14:215\u201321. https:\/\/doi.org\/10.1016\/j.annepidem.2003.08.002.","journal-title":"Ann Epidemiol"},{"key":"1364_CR30","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.3748\/wjg.15.3734","volume":"15","author":"A Dimou","year":"2009","unstructured":"Dimou A, Syrigos KN, Saif MW. Disparities in colorectal cancer in African-Americans vs whites: before and after diagnosis. World J Gastroenterol. 2009;15:3734\u201343. https:\/\/doi.org\/10.3748\/wjg.15.3734.","journal-title":"World J Gastroenterol"},{"key":"1364_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s12885-018-4405-7","volume":"18","author":"MA Healy","year":"2018","unstructured":"Healy MA, Morris AM, Abrahamse P, Ward KC, Kato I, Veenstra CM. The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer. 2018;18:481. https:\/\/doi.org\/10.1186\/s12885-018-4405-7.","journal-title":"BMC Cancer"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-025-01364-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-025-01364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:06:31Z","timestamp":1764842791000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-025-01364-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1007\/s12029-025-01364-z","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"25 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study did not require ethics committee approval as it was not considered human subject research since it was a retrospective review of de-identified data derived from a public database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Dr. Wexner is a consultant for Activ Surgical, Arthex, Baxter, Becton, Dickinson and Co., Intuitive Surgical, OstomyCure, Takeda, and Virtual Ports, has consulting agreements with stock options for consulting with GI View, OstomyCure, and Virtual Ports, is the Data Safety Monitoring Board chair of Polypid, and receives royalties from Intuitive Surgical, Karl Storz Endoscopy America Inc., and Unique Surgical Solutions, LLC. Dr. Emile is a consultant for Becton, Dickinson andCo. Dr. Boutros receives teaching honoraria from Ethicon, Johnson and Johnson.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"237"}}